WELLPHARMA
Latest round
- Series A
Last raised
- May 2022
Total raised
- $1.1M
Investors
- 2
About WELLPHARMA
, operates as an original equipment manufacturing (OEM) company. In May 2022, WELLPHARMA Inc. and MTG Ventures. As of 2022, the company’s CEO is Issei Fukuda. WELLPHARMA manufactures a wide range of products such as CBD (cannabidiol) oil, supplements, gummies, hard capsules, soft drinks, pet oil, cosmetics, and more. In addition, the company also conducts pharmaceutical research on ligands, which are molecules that firmly bind to particular bodily receptors.
Who invested in WELLPHARMA
2 investors across 1 round
See all investors in WELLPHARMA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 12, 2022
Amount
$1.1M
Investors
Questions about WELLPHARMA
Who invested in WELLPHARMA?
WELLPHARMA has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has WELLPHARMA raised?
WELLPHARMA has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did WELLPHARMA last raise money?
WELLPHARMA's most recent round on record is a Series A, in May 2022.
What does WELLPHARMA do?
, operates as an original equipment manufacturing (OEM) company.
Where is WELLPHARMA headquartered?
WELLPHARMA is headquartered in Tokyo, Japan.
Which VCs invest in companies like WELLPHARMA?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back consumer products companies at WELLPHARMA's stage. Their profiles are linked below.
VCs backing consumer products startups at Series A
Raising like WELLPHARMA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.